DrugDashboards

NoHist DM

Chlorpheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride · CHLORPHENIRAMINE MALEATE 4 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mL · Liquid · Oral · Larken Laboratories, Inc.

NDC 68047-0186-16 · 473 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.0673 per mL over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.025$0.05$0.075Nov 2013Sep 2026$0.0673
124 price points · per MLSource: CMS NADAC

Medicaid spend (2025)

$126,197
11,478 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine hydrochloride (other) in the next 90 days

sole-source market · price up 2% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M012
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedMar 15, 2021
    Cardinal Health Inc.CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Manufacturers of Chlorpheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride (Liquid)

LabelerStrengthFirst seenLast seen
Larken Laboratories, Inc.CHLORPHENIRAMINE MALEATE 4 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mLAug 26, 2026Sep 2, 2026
Larken Laboratories, Inc.CHLORPHENIRAMINE MALEATE 4 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 15 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/5mLJul 22, 2026Aug 19, 2026
Larken Laboratories, Inc.CHLORPHENIRAMINE MALEATE 4 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/5mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "NoHist DM — NDC 68047-0186-16," retrieved September 3, 2026, https://drugdashboards.com/drug/68047018616.

Free to cite with attribution — see how the data is put together.